Navigation Links
Video: Keppra XR(TM) Approved in the U.S.
Date:9/14/2008

nts living with epilepsy."

The immediate release tablet form of Keppra(R) (levetiracetam) was first approved by the FDA in 1999 as adjunctive therapy in the treatment of partial onset seizures in adults with epilepsy. Since then, Keppra(R) has become the leading antiepileptic drug in the U.S.

Important Safety Information

Keppra XR(TM) extended-release tablets are indicated as adjunctive therapy in the treatment of partial onset seizures in patients 16 years of age and older with epilepsy.

Keppra XR(TM) causes somnolence, dizziness, and behavioral abnormalities. The most common adverse reactions observed with Keppra XR(TM) in combination with other AEDs were somnolence and irritability.

The adverse reactions that may be seen in patients receiving Keppra XR(TM) are expected to be similar to those seen in patients receiving immediate- release Keppra(R) tablets.

Keppra(R) immediate-release tablets cause somnolence and fatigue, coordination difficulties, and behavioral abnormalities (e.g., psychotic symptoms, suicidal ideation, and other abnormalities), as well as hematological abnormalities. In adults experiencing partial onset seizures, the most common adverse reactions observed with Keppra(R) in combination with other AEDs were somnolence, asthenia, infection and dizziness.

Keppra XR(TM) should be gradually withdrawn to minimize the potential of increased seizure frequency.

Dosing must be individualized according to the patient's renal function status. The dosage should be reduced in patients with impaired renal function receiving Keppra XR. In patients with end stage renal disease on dialysis, it is recommended that immediate-release Keppra(R) be used instead of Keppra XR(TM).

For full prescribing information, please see http://www.KeppraXR.com.

In order to ensure patient access to this valuable medication in the U.S., UCB is initiating a co-pay s
'/>"/>

SOURCE UCB
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. Video: Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck
2. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges
3. Video: Data From 185,000 ICU Admissions Show Significant Reductions in Mortality:
4. Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia
5. Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech
6. Video: CSL Behring Provides $1.2M Grant for Worlds First Study of Postpartum Women with VWD, Common Bleeding Disorder
7. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
8. Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School
9. US FDA Grants Pediatric Exclusivity for UCBs Keppra(R)
10. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder
11. Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... -- Decision Resources, one of the world,s leading ... issues, finds that, owing to the launches of ... will increase more than sevenfold from $790 million ... the United States, France, Germany, Italy, Spain, the ... report entitled Atrial Fibrillation finds that ...
(Date:12/14/2009)... - Results From a Survey Conducted by UCB Assessing ... Countries , , - A third of ... impacts their enjoyment of the festive season, ... shopping for gifts, preparing holiday ... difficult to do, - Nearly ...
(Date:12/11/2009)... Dendreon Corporation (Nasdaq: DNDN ) announced today ... offering have exercised in full their option to ... at the public offering price of $24.75 per ... the size of the offering to an aggregate ... expects to receive net proceeds from the offering ...
(Date:12/11/2009)... new explanation for differences in the severity of mental illness ... the more serious the handicap. The genetic defect is situated ... the amount of copies of the GDI1 gene that is ... Journal of Human Genetics , and are the result of ... a life sciences research institute in Flanders, Belgium at the ...
Breaking Biology Technology:The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Amount of gene surplus determines severity of mental retardation in males 2
... March 13 Covance Inc. (NYSE: ... its clinical pharmacology footprint in Europe with the ... research company based in Basel, Switzerland."Our clients, need ... help them make decisions faster is growing," said ...
... 13 Varian Medical Systems (NYSE: VAR ) ... non-destructive testing market at the upcoming ASNT Research Symposium and ... Hotel in St. Louis, MO.The company will exhibit a number ... , A ...
... Some of the world,s most respected energy experts will be exploring ... the Energy Capital of the World, as the Greater Houston Partnership ... policy by hosting "America,s Energy Future: Assessing Our Paths to Energy ... ...
Other Biology Technology:Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site 2Varian Medical Systems to Exhibit X-ray and CT Technologies for Non-Destructive Testing at the Upcoming ASNT 18th Annual Spring Conference 2Greater Houston Partnership to Lead Energy Security Discussion 2
(Date:12/14/2009)... HOUSTON -- (Dec. 14, 2009) -- Researchers at Rice ... a single nanoparticle that can be tracked in real ... cells, tags them with a fluorescent dye and kills ... the first examples from a growing field called "theranostics" ... treat diseases in a single procedure. , The research ...
(Date:12/14/2009)... and the Biomedical Engineering Society (BMES) have founded a ... CVET ). CVET is a forum ... medical treatment. The first issue of the new ... two other BMES publications at Springer, Annals of ... . , Cardiovascular Engineering and Technology will ...
(Date:12/14/2009)... once thought of tool use as a defining feature of ... other primates, along with birds and an array of other ... Current Biology , a Cell Press publication, adds an ... veined octopus under study manages a behavioral trick that the ... itself over stacked, upright coconut shell "bowls," makes its eight ...
Breaking Biology News(10 mins):Tracking new cancer-killing particles with MRI 2Biomedical Engineering Society's new journal to be published by Springer 2Tool use in an invertebrate: The coconut-carrying octopus 2Swine Flu Infection Rates Continue to Fall 63147 1Swine Flu Infection Rates Continue to Fall 63147 2Swine Flu Infection Rates Continue to Fall 63147 3Abbott Declares 344th Consecutive Quarterly Dividend 63144 1Childrens Hospital Surgeon Receives Prestigious Paul Tessier Medal 63141 1Childrens Hospital Surgeon Receives Prestigious Paul Tessier Medal 63141 2
... years of near-zero growth in atmospheric methane concentrations, levels ... good news for future global warming," says CSIRO,s Dr ... in Geophysical Research Letters, a journal of the American ... important greenhouse gases, namely methane and the CFCs, had ...
... L-1 to Open 75+ Centers and Expects to Process ... Requiring,Fingerprint-based Background Checks, STAMFORD, Conn., Oct. 29 ... provider of identity solutions and,services, was selected by the ... a,five-year contract estimated at up to $250 million to ...
... Whether it,s in the human body or under the ... Physicians and geologists will be meeting at the University of ... , Through a partnership between UH, M.D. Anderson ... seismic imaging will gather to explore the potential for cross-collaboration ...
Other Biology News:Global methane levels on the rise again 2L-1 Identity Solutions Selected by the State of New York as the Winning Bidder to Provide Enrollment Services for a Contract Estimated at Up to $250 Million 2L-1 Identity Solutions Selected by the State of New York as the Winning Bidder to Provide Enrollment Services for a Contract Estimated at Up to $250 Million 3L-1 Identity Solutions Selected by the State of New York as the Winning Bidder to Provide Enrollment Services for a Contract Estimated at Up to $250 Million 4Similarities in imaging the human body, Earth's crust focus of conference at UH 2
ID clarifier: With ethidium bromide (50 μg/ml)...
... C2C12 cells were cultured in DMEM and harvested ... order to keep the antigens in their native ... cells are arrayed on a 12-well (5 mm) ... treated to enhance cellular attachment and to minimize ...
... for optimal colony growth; ... growth of anchorage-dependent cells. ... colony-forming assays of human ... Not suitable for long-term ...
... is a convenient, premixed, formamide-containing ... and Perfect RNA Markers. This ... dilution and is suitable for ... mix equal volumes of RNA ...
Biology Products: